The Development of Optogenetics and its Potential to Cure Blindness


  • Muthu Panchanatham University of California, San Diego



Optogenetics, Blindness, Cure, Retinitis Pigmentosa


In humans, sight resides atop the hierarchy of senses. Eyes allow people to perceive the world around them, interpret information they observe, and make informed decisions when faced with new situations. Without vision, a person can no longer connect with their surroundings, leaving them vulnerable to physical dangers and the socioeconomic consequences of blindness (Khanna et al., 2007). Blind individuals have a 44.2% employment rate compared to a 77.2% employment rate for people without disabilities according to the American Community Survey (ACS). Additionally, blind individuals have jobs with lower salaries (McDonnall et al., 2019). A cure for blindness would prove invaluable as over 1.1 million people in the United States are considered legally blind. Despite centuries of research into the prospect of restoring sight, a panacea remains unknown. However, modern advancements in biotechnology and gene therapy offer promising results in helping individuals regain their vision. One such novel technique is optogenetics, an approach that involves genetically modifying cells so that they can sense light, allowing the precise manipulation of neural activity. Researchers hypothesize that through optogenetics, light activated cells could replace damaged sensory cells in the retina, possibly mitigating photoreceptor-related impairments to a person’s sight. Here, we delve into new optogenetic therapies being developed to cure blindness. First, we provide a brief summary of the visual system, discuss the advent of optogenetic research in its early stages, and finally analyze how this technology has been implemented as a method to restore sight in animal models and a human case study. 


Download data is not yet available.


Metrics Loading ...

References or Bibliography

Khanna, R., Raman, U. and Rao, G.N. (2007), Blindness and poverty in India: the way forward. Clinical and Experimental Optometry, 90: 406-414.

McDonnall MC, McKnight ZS. The Association Between Presenting Visual Impairment, Health, and Employment Status. Journal of Visual Impairment & Blindness. 2021;115(3):204-214.

Dingcai Cao, Chapter 10 - Color Vision and Night Vision, Editor(s): Stephen J. Ryan, SriniVas R. Sadda, David R. Hinton, Andrew P. Schachat, SriniVas R. Sadda, C.P. Wilkinson, Peter Wiedemann, Andrew P. Schachat, Retina (Fifth Edition), W.B. Saunders, 2013, Pages 285-299, ISBN 9781455707379,

Joseph Feher, 4.8 - Vision, Editor(s): Joseph Feher, Quantitative Human Physiology, Academic Press, 2012, Pages 386-400, ISBN 9780123821638,

F. Wang, Axon Guidance: Building Pathways with Molecular Cues in Vertebrate Sensory Systems, Editor(s): Larry R. Squire, Encyclopedia of Neuroscience, Academic Press, 2009, Pages 1073-1079, ISBN 9780080450469,

A.D. Milner, Visual Systems: Dorsal and Ventral, Editor(s): Neil J. Smelser, Paul B. Baltes, International Encyclopedia of the Social & Behavioral Sciences, Pergamon, 2001, Pages 16285-16288, ISBN 9780080430768,

Heath Jeffery RC, Mukhtar SA, McAllister IL, Morgan WH, Mackey DA, Chen FK. Inherited retinal diseases are the most common cause of blindness in the working-age population in Australia. Ophthalmic Genet. 2021 Aug;42(4):431-439.

Fenno L, Yizhar O, Deisseroth K. The development and application of optogenetics. Annu Rev Neurosci. 2011;34:389-412.

Bitzenhofer SH, Ahlbeck J, Wolff A, Wiegert JS, Gee CE, Oertner TG, Hanganu-Opatz IL. Layer-specific optogenetic activation of pyramidal neurons causes beta-gamma entrainment of neonatal networks. Nat Commun. 2017 Feb 20;8:14563.

Osakada F, Callaway EM. Design and generation of recombinant rabies virus vectors. Nat Protoc. 2013 Aug;8(8):1583-601.

Adamantidis, A., Zhang, F., Aravanis, A. et al. Neural substrates of awakening probed with optogenetic control of hypocretin neurons. Nature 450, 420–424 (2007).

Oka Y, Ye M, Zuker CS. Thirst driving and suppressing signals encoded by distinct neural populations in the brain. Nature. 2015 Apr 16;520(7547):349-52.

McClements ME, Staurenghi F, MacLaren RE, Cehajic-Kapetanovic J. Optogenetic Gene Therapy for the Degenerate Retina: Recent Advances. Front Neurosci. 2020 Nov 11;14:570909.

van Wyk M, Pielecka-Fortuna J, Löwel S, Kleinlogel S. Restoring the ON Switch in Blind Retinas: Opto-mGluR6, a Next-Generation, Cell-Tailored Optogenetic Tool. PLoS Biol. 2015 May 7;13(5):e1002143.

Gauvain G, Akolkar H, Chaffiol A, Arcizet F, Khoei MA, Desrosiers M, Jaillard C, Caplette R, Marre O, Bertin S, Fovet CM, Demilly J, Forster V, Brazhnikova E, Hantraye P, Pouget P, Douar A, Pruneau D, Chavas J, Sahel JA, Dalkara D, Duebel J, Benosman R, Picaud S. Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates. Commun Biol. 2021 Jan 27;4(1):125.

White M, Mackay M, Whittaker R. Taking Optogenetics into the Human Brain: Opportunities and Challenges in Clinical Trial Design. Open Access J Clin Trials. 2020 Aug 25;2020:33-41.

Shen Yi, Campbell Robert E., Côté Daniel C., Paquet Marie-Eve. Challenges for Therapeutic Applications of Opsin-Based Optogenetic Tools in Humans. Frontiers in Neural Circuits. Vol. 14, 2020

Sahel, JA., Boulanger-Scemama, E., Pagot, C. et al. Partial recovery of visual function in a blind patient after optogenetic therapy. Nat Med 27, 1223–1229 (2021).

Paz JT, Davidson TJ, Frechette ES, Delord B, Parada I, Peng K, Deisseroth K, Huguenard JR. Closed-loop optogenetic control of thalamus as a tool for interrupting seizures after cortical injury. Nat Neurosci. 2013 Jan;16(1):64-70.

Samineni VK, Mickle AD, Yoon J, Grajales-Reyes JG, Pullen MY, Crawford KE, Noh KN, Gereau GB, Vogt SK, Lai HH, Rogers JA, Gereau RW 4th. Optogenetic silencing of nociceptive primary afferents reduces evoked and ongoing bladder pain. Sci Rep. 2017 Nov 20;7(1):15865.

Long X, Ye J, Zhao D, Zhang SJ. Magnetogenetics: remote non-invasive magnetic activation of neuronal activity with a magnetoreceptor. Sci Bull (Beijing). 2015;60:2107-2119.

Wai Kit David Chee, Jing Wui Yeoh, Viet Linh Dao, Chueh Loo Poh, Thermogenetics: Applications come of age, Biotechnology Advances, Volume 55, 2022, 107907, ISSN 0734-9750

Duque, M., Lee-Kubli, C.A., Tufail, Y. et al. Sonogenetic control of mammalian cells using exogenous Transient Receptor Potential A1 channels. Nat Commun 13, 600 (2022).

[The structure of the retina with its various types of cells labeled]. (2016, January 26). Discovery Eye Foundation.

Zapalac, M. A. (n.d.). How the Eye Works. Saint Luke's. Retrieved from

Nieto, M. P. (2015, January 15). [A simplified schema of the human visual pathway].


Lyon, K. (n.d.). How does optogenetics work? Science in the News. Harvard University. Retrieved from



How to Cite

Panchanatham, M. (2023). The Development of Optogenetics and its Potential to Cure Blindness . Journal of Student Research, 12(1).



Review Articles